Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".
Woody G, Bruce D, Korthuis PT, Chhatre S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Poole S, Metzger D, Ling W.
Woody G, et al.
J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):e142-3. doi: 10.1097/QAI.0000000000000344.
J Acquir Immune Defic Syndr. 2014.
PMID: 25243431
Free PMC article.
No abstract available.